Drug · DIN 00028096
CELESTONE SOLUSPAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 4, 2022; first marketed December 31, 1965.
- Drug Identification Number (DIN)
- 00028096
- Company (DIN owner)
- Organon Canada Inc.Kirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Intra-Articular; Intramuscular; Intrabursal; Intradermal
- Therapeutic class (ATC)
- Betamethasone H02AB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BETAMETHASONE ACETATE | 3 MG | ML |
| BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) | 3 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 20, 2021: NOC 25699New Drug Submission (NDS) · Change in product ownership
- February 15, 2011: NOC 12069New Drug Submission (NDS) · Manufacturer name change
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “celestone”. A notice may cover another product or only some lots: read it to see what it covers.
- Celestone Soluspan: Affected lots may contain the presence of foreign matter.January 31, 2023 · Drugs · Product quality · Type II